IL-17A in the Psoriatic Patients’ Serum and Plaque Scales as Potential Marker of the Diseases Severity and Obesity

Table 2

The correlation between IL-17 serum, scale concentration and clinical features and disease severity in psoriatic patients; statistically significant correlation.

Variable	IL-17 serum concentration		IL-17 scale concentration
	Age	-0.413	0.063	-0.266	0.243
Age of psoriatic onset	-0.420	0.058	-0.064	0.782
Duration of psoriasis	0.103	0.657	-0.214	0.351
BMI	-0.186	0.435	-0.482	0.028
PASI	0.610	0.003	0.316	0.163
PGA	0.542	0.011	0.256	0.263
BSA	0.608	0.003	0.436	0.048
DLQI	0.503	0.020	0.165	0.476
NAPSI	0.297	0.191	0.245	0.284